Recent Updates
Recently added Catalysts
RDY Neutral Sentiment Score: 55/100

National Stock Exchange of India Ltd.

Key Takeaway: Dr. Reddy's Laboratories Limited announced that the Board of Directors will consider the proposal for recommending the final dividend for the fiscal year 2025-26. This follows an earlier communication made on March 23, 2026. The decision regarding the dividend will be deliberated in an upcoming board meeting. No specific details about the dividend amount or other financial aspects were disclosed in the announcement.
Price reaction · baseline $12.94 (2026-04-15 close) · hit after-hours · clean, no other RDY news in the window
day 0 close · peak
+0.9%

Market Sentiment Analysis

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
With reference to the subject cited above and in continuation, to our earlier intimation dated March 23, 2026, this is to bring to your kind notice that the Board of Directors will consider, inter alia, the proposal for recommending the final dividend for FY 2025-26, if any.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR

Frequently Asked Questions

What is the stock code for Dr. Reddy's on the NYSE?

The stock code for Dr. Reddy's on the NYSE is RDY.

When will the Board consider the final dividend proposal?

The Board will consider the final dividend proposal on March 23, 2026.

What is the BSE stock code for Dr. Reddy's Laboratories?

The BSE stock code for Dr. Reddy's Laboratories is 500124.

Who is the Compliance Officer for Dr. Reddy's Laboratories?

The Company Secretary, Compliance Officer, and Head-CSR is the Compliance Officer.

What does the BSE intimation refer to?

The BSE intimation refers to the proposal for the final dividend for FY 2025-26.

Last updated: Apr 16, 2026